for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

FMC Corp

FMC

Latest Trade

107.78USD

Change

0.29(+0.27%)

Volume

413,419

Today's Range

107.50

 - 

108.90

52 Week Range

56.77

 - 

113.73

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
107.49
Open
108.44
Volume
413,419
3M AVG Volume
13.12
Today's High
108.90
Today's Low
107.50
52 Week High
113.73
52 Week Low
56.77
Shares Out (MIL)
129.57
Market Cap (MIL)
13,829.91
Forward P/E
--
Dividend (Yield %)
1.65

Next Event

Q3 2020 FMC Corp Earnings Release

Latest Developments

More

FMC Corporation Raises Full-Year 2020 Guidance Following A Solid Second Quarter Result

FMC Sets Regular Quarterly Dividend Of $0.44 Per Share

FMC Corporation to Acquire Fluindapyr Active Ingredient Assets from Isagro S.p.A

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About FMC Corp

FMC Corporation is an agricultural sciences company. The Company provides solutions to growers with product portfolio integrated with discovery and development pipeline in crop protection, plant health, and pest and turf management. The Company operates in a single business segment and develops, markets and sells three classes of crop protection chemicals: insecticides, herbicides and fungicides. Its products are used in agriculture to manage crop yield and quality by controlling a spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The Company’s combination of technologies includes insect control products based on Rynaxypyr and Cyazypyr active ingredients; Authority, Boral, Centium, Command and Gamit branded herbicides; Talstar and Hero branded insecticides; and flutriafol-based fungicides. The Company’s portfolio also includes biologicals such as Quartzo and Presence bionematicides.

Industry

Chemical Manufacturing

Contact Info

2929 Walnut St

PHILADELPHIA, PA

19104-5054

United States

+1.215.2996668

http://www.fmc.com

Executive Leadership

Pierre Pierre Brondeau

Executive Chairman of the Board

Mark A. Douglas

President, Chief Executive Officer

Andrew D. Sandifer

Chief Financial Officer, Executive Vice President

Michael Finian Reilly

Executive Vice President, General Counsel, Chief Compliance Officer and Secretary

Paul W. Graves

Executive Vice President and Chief Executive Officer - Lithium Business

Key Stats

1.91 mean rating - 23 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

2.9K

2018

4.7K

2019

4.6K

2020(E)

4.7K
EPS (USD)

2017

2.710

2018

6.290

2019

6.090

2020(E)

6.494
Price To Earnings (TTM)
25.36
Price To Sales (TTM)
3.00
Price To Book (MRQ)
4.90
Price To Cash Flow (TTM)
19.59
Total Debt To Equity (MRQ)
125.20
LT Debt To Equity (MRQ)
107.27
Return on Investment (TTM)
7.96
Return on Equity (TTM)
5.56

Latest News

Latest News

UPDATE 3-Fresenius cuts 2020 outlook on pandemic impact

* Shares down 4% (Adds details from conference call, updates shares)

FMC must pay tribes more than $25 million for hazardous waste storage: 9th Circuit

Chemical company FMC Corp must pay more than $25 million to the Shoshone-Bannock Tribes in accrued annual fees for storing hazardous waste on reservation land in Idaho, a federal appeals court said on Friday.

UPDATE 3-Fresenius beats Q3 forecasts with strong sales of home dialysis treatments

* Fresenius highlights infusion drugs unit growth in emerging markets (Adds details from conference call and analyst comments, updates share price)

UPDATE 4-Fresenius slides as weakness in dialysis unit offsets improved outlook

* Fresenius expects FY 4%-7% revenue growth at constant currency

Lithium-producer Livent says FMC sale to bring certainty for staff, investors

Lithium producer Livent Corp says majority owner FMC Corp's decision to sell its entire stake by next spring will help it better compete in the fast-moving sector, Chief Executive Paul Graves said on Tuesday.

Livent sees FMC exit as bringing 'more certainty' to operations

Livent Corp sees majority owner FMC Corp's decision to sell its entire stake by next spring as a step that will help it better compete in the fast-moving lithium market, the company's chief executive said on Tuesday.

Livent profit fails to beat expectations; shares drop

Livent Corp <LTMN.N>, the lithium producer spun off last month from FMC Corp <FMC.N>, cut its 2018 sales forecast and posted a quarterly profit on Monday that failed to exceed Wall Street's expectations, sending its shares down nearly 4 percent in after-hours trading.

Livent quarterly profit jumps 18 percent on rising lithium demand

Livent Corp, the lithium producer spun off last month from FMC Corp, said on Monday its quarterly profit rose 18 percent due to rising demand for the white metal, a key component of electric car batteries.

UPDATE 2-Fresenius Medical Care says expects weaker growth in Q4

* Deadline for NxStage Medical takeover extended (Adds share price, analyst)

Exclusive: Lithium producer Albemarle eyes buying rival if IPO stumbles - source

Albemarle Corp <ALB.N>, the world's largest lithium producer, could buy FMC Corp's <FMC.N> lithium division if the smaller rival's initial public offering stumbles this fall, a senior executive told investors at an event in June, according to a source who attended.

FMC says lithium pricing rising on strong electric car demand

FMC Corp, which is spinning off its lithium division as a publicly traded company later this year, said on Thursday that prices for the light metal continue to rise on strong demand from electric vehicle battery makers.

UPDATE 1-FMC's quarterly profit beats expectations as lithium sales jump

FMC Corp, the chemical producer spinning off its lithium division as a publicly traded company later this year, posted a better-than-expected quarterly profit on Wednesday as sales of the mineral used to make electric vehicle batteries surged.

FMC's quarterly profit nearly doubles as lithium sales jump

FMC Corp, the chemical producer spinning off its lithium division as a publicly traded company later this year, posted a quarterly profit on Wednesday that nearly doubled.

Akorn row overshadows Fresenius' generics guidance

Fears that a legal dispute with U.S. drugmaker Akorn could extend into next year overshadowed improved guidance from Germany's Fresenius SE for its Kabi generics business.

BRIEF-FMC Mark Douglas Appointed President And COO

* FMC CORP - MARK DOUGLAS, PRESIDENT OF FMC AGRICULTURAL SOLUTIONS, HAS BEEN APPOINTED PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage:

FMC sees strong outlook for lithium demand, prices

FMC Corporation "on track" for lithium IPO in October 2018 - CEO Pierre Brondeau FMC Corp says lithium customers increasingly seeking long-term supply commitments - CEO FMC Corp says nearly 60% of agriculture business EBITDA expected in first-half 2018, reversing pattern...

BRIEF-FMC Corporation Qtrly Consolidated Adjusted Earnings Per Diluted Share Of $1.84

* SEES FY 2018 REVENUE UP 2.5 PERCENT FOR FMC AGRICULTURAL SOLUTIONS

Fresenius Medical sells U.S. Sound Inpatient for $2.15 billion

German dialysis specialist Fresenius Medical Care <FMEG.DE> is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion, it said on Saturday.

BRIEF-China City Infrastructure Group Announces Formation Of JV Private Equity Fund Management Co

* UNIT, CITIC ZHENG YE & BEIJING HUA BIN TO SET UP FMC, A JV PRIVATE EQUITY FUND MANAGEMENT CO

BRIEF-FMC Corp Sees Q1 Adjusted EPS Exceed $1.45 - $1.59 Range

* FMC GIVES UPDATE ON EXPECTED PERFORMANCE FOR FIRST QUARTER AND FULL YEAR 2018 AHEAD OF SCHEDULED MEETING WITH INVESTORS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up